Development of monoclonal antibody-based immunoassays for quantification and rapid assessment of dihydroartemisinin contents in antimalarial drugs
X Ning, W Li, M Wang, S Guo, G Tan, B Wang… - … of pharmaceutical and …, 2018 - Elsevier
Dihydroartemisinin (DHA) is one of the artemisinin derivatives widely used in artemisinin-
based combination therapies (ACTs) for malaria treatment. The availability of a point-of-care …
based combination therapies (ACTs) for malaria treatment. The availability of a point-of-care …
Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007–2015): In vivo response and dhfr and dhps mutations
Q Kakar, S Sheikh, I Ahmed, MA Khan, M Jamil… - Acta Tropica, 2016 - Elsevier
Abstract Artesunate+ sulfadoxine-pyrimethamine (AS+ SP) and artemether+ lumefantrine
(AL) are the first-and second line treatments, respectively, for the treatment of falciparum …
(AL) are the first-and second line treatments, respectively, for the treatment of falciparum …
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in …
AT Mori, F Ngalesoni, OF Norheim, B Robberstad - Malaria journal, 2014 - Springer
Abstract Background Dihydroartemisinin-piperaquine (DhP) is highly recommended for the
treatment of uncomplicated malaria. This study aims to compare the costs, health benefits …
treatment of uncomplicated malaria. This study aims to compare the costs, health benefits …
Antiprotozoal Drugs
S Thurston, GL Hite, AN Petry, SD Ray - Side Effects of Drugs Annual, 2015 - Elsevier
Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. The series supplements the …
effects of drugs and adverse reactions to them are surveyed. The series supplements the …
Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana
Background Uncommon and rare adverse events (AEs), with delayed onset may not be
detected before new drugs are licensed and deployed. The present study examined the post …
detected before new drugs are licensed and deployed. The present study examined the post …
The effect of sambiloto and spirulina combination on Mucin-1 protein expression in medial colon of Plasmodium berghei ANKA infected mice
K Kusmardi, BN Hairi, NS Lubis, TW Lestari… - Pharmacognosy …, 2021 - phcogj.com
Malaria still be health problem in the world, especially in Eastern Indonesia. Malaria's
inflammation and metabolism defect can cause colonic damage, such as enhancement Muc …
inflammation and metabolism defect can cause colonic damage, such as enhancement Muc …
Budget Impact Analysis of Using Dihydroartemisinin–Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania
AT Mori, OF Norheim, B Robberstad - PharmacoEconomics, 2016 - Springer
Abstract Background and Objective Dihydroartemisinin–piperaquine (DhP) is a very cost
effective anti-malarial drug. The aim of this study was to predict the budget impact of using …
effective anti-malarial drug. The aim of this study was to predict the budget impact of using …
Transfusion‐transmitted malaria masquerading as sickle cell crisis with multisystem organ failure
BACKGROUND Fever accompanying vaso‐occlusive crisis is a common presentation in
patients with sickle cell disease (SCD) and carries a broad differential diagnosis. Here, we …
patients with sickle cell disease (SCD) and carries a broad differential diagnosis. Here, we …
Reappraising the cardiosafety of dihydroartemisinin-piperaquine
P Millat-Martínez, Q Bassat - The Lancet Infectious Diseases, 2018 - thelancet.com
The arsenal of efficacious drugs for the treatment of malaria remains small and is clearly
insufficient to tackle the global burden of malaria, with more than 216 million clinical …
insufficient to tackle the global burden of malaria, with more than 216 million clinical …